100+
paid subscribers
1K+
free subscribers

The M&A Hunter

About the Substack

Tracking biotech acquisition targets before big pharma strikes. Featuring acquisition targets with detailed analysis M&A probability signals and catalysts Valuation insight and deal timing estimates Big pharma strategy patterns "NOT Pro Advice"

Free Subscription Benefits

  • โ€ข Weekly M&A Radar: Quick analysis of 3-5 acquisition targets โ€ข Monthly Deep-Dive: One featured target with full research โ€ข Track Record: Updates on completed acquisition

Paid Subcription Benefits

  • Full Weekly Analysis: Detailed research on all active targets โ€ข M&A Probability Scores: Data-driven acquisition likelihood (0-100%)
  • โ€ข Target Prices: Estimated acquisition price ranges and upside potential โ€ข Complete Database: Access to all 14+ active targets with ongoing updates
  • โ€ข Deal Alerts: Immediate notifications when M&A deals are announced โ€ข Community Access: Comment on posts and join monthly Q&A sessions

Paid Subscription Plans

  • $100 a year
  • $10 a month

About The M&A Hunter

Tracking biotech & Banking acquisition targets Featuring acquisition targets with detailed analysis M&A probability signals and catalysts Valuation insight and deal timing estimates Big pharma strategy patterns "NOT Pro Advice"

Subscriber Growth

The number of free subscribers for The M&A Hunter over time since it was added to the directory.

Is this your Substack? Submit changes.

The M&A Hunter's recommended Substacks

22nd Century Frontierโ„ข logo
Petar Dimov

22nd Century Frontierโ„ข

Building or Investing in the Future? This Newsletter Is Your Edge

15K+
free subscribers
Helix logo
Sowmy VJ

Helix

Helix Research (London): Exploiting Mispriced Balance Sheet Resilience. Rules based. High conviction core. Structured pipeline. Profit first. Listed equities only.

3K+
free subscribers
Joe Duarte's Smart Money Passport logo
Joe Duarte

Joe Duarte's Smart Money Passport

Joe Duarte is author of the Best Seller "Options Trading for Dummies." Stock market analysis for active traders and long term investors. Buy/Sell strategies for stocks, options, and ETFs.

100+
paid subscribers
1K+
free subscribers
Jim Melvin's Realms of Fantasy logo
Jim Melvin

Jim Melvin's Realms of Fantasy

I am a novelist whose main focus is epic and dark fantasy but who also writes a wide range of fiction and nonfiction. Please sign up to receive my free newsletter.

3K+
free subscribers
Young Bull logo
Youngbull

Young Bull

The Physical Layer of AI, and how I'm playing it. Real portfolio. Time-stamped trades. Receipts, not predictions.